ALLO
Allogene Therapeutics, Inc. · Healthcare
Director Owen N. Witte sold $251K of Allogene Therapeutics, Inc.
Sold$251,250
$16.75Price
15,000Shares
−6%Stake
What ALLO did after the filing
- The stock from Tue, Aug 16 open, $17.23
- −33.7%
- S&P 500, same days
- −13.0%
Measured over 30 trading days, to the Sep 28 close.
Traded Thu, Aug 11. Filed Mon, Aug 15. Returns use the Aug 16 open and the Sep 28 close. Not investment advice.